<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe the use of abciximab to prevent rethrombosis of the basilar artery after transluminal angioplasty </plain></SENT>
<SENT sid="1" pm="."><plain>A 60-year-old patient with vertebral <z:e sem="disease" ids="C0004812" disease_type="Disease or Syndrome" abbrv="">basilar insufficiency</z:e> and <z:hpo ids='HP_0011009'>acute</z:hpo> occlusion of the basilar artery underwent revascularization with urokinase and angioplasty </plain></SENT>
<SENT sid="2" pm="."><plain>Despite the repeated use of urokinase and angioplasty under anticoagulation with <z:chebi fb="5" ids="28304">heparin</z:chebi>, the basilar artery immediately rethrombosed </plain></SENT>
<SENT sid="3" pm="."><plain>In a final attempt to prevent rethrombosis, abciximab was administered before the final angioplasty, resulting in a widely patent basilar artery and no rethrombosis </plain></SENT>
</text></document>